The innate immune system, toll-like receptors and dermal wound healing: A review

Vascular Pharmacology

Volumn 71, Issue , 2015, Pages 31-36

  Portou, M J ^a   Baker, D ^a   Abraham, D ^a   Tsui, J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Diabetes; Innate immune system; Wound healing

Indexed keywords

TOLL LIKE RECEPTOR;

DIABETES MELLITUS; DIABETIC FOOT; HUMAN; INFLAMMATION; INNATE IMMUNITY; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SCAR; SIGNAL TRANSDUCTION; SKIN FIBROSIS; SKIN HYPERTROPHY; SKIN INJURY; SKIN ULCER; WOUND COMPLICATION; WOUND HEALING; ANGIOGENESIS; ANIMAL; CELL PROLIFERATION; IMMUNOLOGY; INJURIES; METABOLISM; PHYSIOLOGY; SKIN;

ANIMALS; CELL PROLIFERATION; HUMANS; IMMUNITY, INNATE; INFLAMMATION; NEOVASCULARIZATION, PHYSIOLOGIC; SKIN; TOLL-LIKE RECEPTORS; WOUND HEALING;

EID: 84937869611     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2015.02.007     Document Type: Review

References (58)

1. Hubner G., Brauchle M., Smola H., Madlener M., Fassler R., Werner S. Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid-treated mice. Cytokine 1996, 8(7):548-556.
2. Guo S., Dipietro L.A. Factors affecting wound healing. J Dent Res 2010, 89(3):219-229.
3. Roupe K.M., Nybo M., Sjobring U., Alberius P., Schmidtchen A., Sorensen O.E. Injury is a major inducer of epidermal innate immune responses during wound healing. J Invest Dermatol 2010, 130(4):1167-1177.
4. Kim M.H., Liu W., Borjesson D.L., Curry F.R., Miller L.S., Cheung A.L., Liu F.T., Isseroff R.R., Simon S.I. Dynamics of neutrophil infiltration during cutaneous wound healing and infection using fluorescence imaging. J Invest Dermatol 2008, 128(7):1812-1820.
5. Segal A.W. How neutrophils kill microbes. Annu Rev Immunol 2005, 23:197-223.
6. Acosta J.B., del Barco D.G., Vera D.C., Savigne W., Lopez-Saura P., Guillen Nieto G., Schultz G.S. The pro-inflammatory environment in recalcitrant diabetic foot wounds. Int Wound J 2008, 5(4):530-539.
7. Suga H., Sugaya M., Fujita H., Asano Y., Tada Y., Kadono T., Sato S. TLR4, rather than TLR2, regulates wound healing through TGF-beta and CCL5 expression. J Dermatol Sci 2014, 73(2):117-124.
8. DiPietro L.A. Wound healing: the role of the macrophage and other immune cells. Shock 1995, 4(4):233-240.
9. Deodhar A.K., Rana R.E. Surgical physiology of wound healing: a review. J Postgrad Med 1997, 43(2):52-56.
10. Fishel R.S., Barbul A., Beschorner W.E., Wasserkrug H.L., Efron G. Lymphocyte participation in wound healing. Morphologic assessment using monoclonal antibodies. Ann Surg 1987, 206(1):25-29.
11. Park J.E., Barbul A. Understanding the role of immune regulation in wound healing. Am J Surg 2004, 187(5A):11S-16S.
12. Jameson J., Havran W.L. Skin gammadelta T-cell functions in homeostasis and wound healing. Immunol Rev 2007, 215:114-122.
13. Traversa B., Sussman G. The role of growth factors, cytokines and proteases in wound management. Prim Intention 2001, 9(4):161-167.
14. Wild T., Rahbarnia A., Kellner M., Sobotka L., Eberlein T. Basics in nutrition and wound healing. Nutrition 2010, 26(9):862-866.
15. Gilbane A.J., Denton C.P., Holmes A.M. Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells. Arthritis Res Ther 2013, 15(3):215.
16. O'Toole E.A. Extracellular matrix and keratinocyte migration. Clin Exp Dermatol 2001, 26(6):525-530.
17. Raja Sivamani K., Garcia M.S., Isseroff R.R. Wound re-epithelialization: modulating keratinocyte migration in wound healing. Front Biosci 2007, 12:2849-2868.
18. Haase I., Evans R., Pofahl R., Watt F.M. Regulation of keratinocyte shape, migration and wound epithelialization by IGF-1- and EGF-dependent signalling pathways. J Cell Sci 2003, 116(Pt 15):3227-3238.
19. Martins V.L., Caley M., O'Toole E.A. Matrix metalloproteinases and epidermal wound repair. Cell Tissue Res 2013, 351(2):255-268.
20. Amano S., Akutsu N., Ogura Y., Nishiyama T. Increase of laminin 5 synthesis in human keratinocytes by acute wound fluid, inflammatory cytokines and growth factors, and lysophospholipids. Br J Dermatol 2004, 151(5):961-970.
21. Usui M.L., Mansbridge J.N., Carter W.G., Fujita M., Olerud J.E. Keratinocyte migration, proliferation, and differentiation in chronic ulcers from patients with diabetes and normal wounds. J Histochem Cytochem 2008, 56(7):687-696.
22. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124(4):783-801.
23. Staros E.B. Innate immunity: new approaches to understanding its clinical significance. Am J Clin Pathol 2005, 123(2):305-312.
24. Spirig R., Tsui J., Shaw S. The emerging role of TLR and innate immunity in cardiovascular disease. Cardiol Res Pract 2012, 2012:181394.
25. Gordon S. Pattern recognition receptors: doubling up for the innate immune response. Cell 2002, 111(7):927-930.
26. Areschoug T., Gordon S. Pattern recognition receptors and their role in innate immunity: focus on microbial protein ligands. Contrib Microbiol 2008, 15:45-60.
27. Patel H., Shaw S.G., Shi-Wen X., Abraham D., Baker D.M., Tsui J.C. Toll-like receptors in ischaemia and its potential role in the pathophysiology of muscle damage in critical limb ischaemia. Cardiol Res Pract 2012, 2012:121237.
28. Navi A., Patel H., Shaw S., Baker D., Tsui J. Therapeutic role of toll-like receptor modification in cardiovascular dysfunction. Vascul Pharmacol 2013, 58(3):231-239.
29. Mann D.L. The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls. Circ Res 2011, 108(9):1133-1145.
30. De Nardo D., De Nardo C.M., Nguyen T., Hamilton J.A., Scholz G.M. Signaling crosstalk during sequential TLR4 and TLR9 activation amplifies the inflammatory response of mouse macrophages. J Immunol 2009, 183(12):8110-8118.
31. Huebener P., Schwabe R.F. Regulation of wound healing and organ fibrosis by toll-like receptors. Biochim Biophys Acta 2013, 1832(7):1005-1017.
32. Alexander C., Rietschel E.T. Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res 2001, 7(3):167-202.
33. Sato T., Yamamoto M., Shimosato T., Klinman D.M. Accelerated wound healing mediated by activation of toll-like receptor 9. Wound Repair Regen 2010, 18(6):586-593.
34. Matzinger P. The danger model: a renewed sense of self. Science 2002, 296(5566):301-305.
35. Dasu M.R., Ramirez S., Isseroff R.R. Toll-like receptors and diabetes: a therapeutic perspective. Clin Sci (Lond) 2012, 122(5):203-214.
36. Terhorst D., Kalali B.N., Ollert M., Ring J., Mempel M. The role of toll-like receptors in host defenses and their relevance to dermatologic diseases. Am J Clin Dermatol 2010, 11(1):1-10.
37. Pasparakis M., Haase I., Nestle F.O. Mechanisms regulating skin immunity and inflammation. Nat Rev Immunol 2014, 14(5):289-301.
38. Miller L.S., Modlin R.L. Human keratinocyte toll-like receptors promote distinct immune responses. J Invest Dermatol 2007, 127(2):262-263.
39. Miller L.S., Sorensen O.E., Liu P.T., Jalian H.R., Eshtiaghpour D., Behmanesh B.E., Chung W., Starner T.D., Kim J., Sieling P.A., et al. TGF-alpha regulates TLR expression and function on epidermal keratinocytes. J Immunol 2005, 174(10):6137-6143.
40. Miller L.S., Modlin R.L. Toll-like receptors in the skin. Semin Immunopathol 2007, 29(1):15-26.
41. Jang S., Park J.S., Won Y.H., Yun S.J., Kim S.J. The expression of toll-like receptors (TLRs) in cultured human skin fibroblast is modulated by histamine. Chonnam Med J 2012, 48(1):7-14.
42. Wang J., Hori K., Ding J., Huang Y., Kwan P., Ladak A., Tredget E.E. Toll-like receptors expressed by dermal fibroblasts contribute to hypertrophic scarring. J Cell Physiol 2011, 226(5):1265-1273.
43. Taylor K.R., Trowbridge J.M., Rudisill J.A., Termeer C.C., Simon J.C., Gallo R.L. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 2004, 279(17):17079-17084.
44. Dasu M.R., Isseroff R.R. Toll-like receptors in wound healing: location, accessibility, and timing. J Invest Dermatol 2012, 132(8):1955-1958.
45. Chen L., Guo S., Ranzer M.J., DiPietro L.A. Toll-like receptor 4 has an essential role in early skin wound healing. J Invest Dermatol 2013, 133(1):258-267.
46. Dasu M.R., Thangappan R.K., Bourgette A., DiPietro L.A., Isseroff R., Jialal I. TLR2 expression and signaling-dependent inflammation impair wound healing in diabetic mice. Lab Invest 2010, 90(11):1628-1636.
47. Dasu M.R., Jialal I. Amelioration in wound healing in diabetic toll-like receptor-4 knockout mice. J Diabetes Complications 2013, 27(5):417-421.
48. Pukstad B.S., Ryan L., Flo T.H., Stenvik J., Moseley R., Harding K., Thomas D.W., Espevik T. Non-healing is associated with persistent stimulation of the innate immune response in chronic venous leg ulcers. J Dermatol Sci 2010, 59(2):115-122.
49. Lin Q., Fang D., Fang J., Ren X., Yang X., Wen F., Su S.B. Impaired wound healing with defective expression of chemokines and recruitment of myeloid cells in TLR3-deficient mice. J Immunol 2011, 186(6):3710-3717.
50. Lin Q., Wang L., Lin Y., Liu X., Ren X., Wen S., Du X., Lu T., Su S.Y., Yang X., et al. Toll-like receptor 3 ligand polyinosinic:polycytidylic acid promotes wound healing in human and murine skin. J Invest Dermatol 2012, 132(8):2085-2092.
51. Fadini G.P., Albiero M., Menegazzo L., Boscaro E., Pagnin E., Iori E., Cosma C., Lapolla A., Pengo V., Stendardo M., et al. The redox enzyme p66Shc contributes to diabetes and ischemia-induced delay in cutaneous wound healing. Diabetes 2010, 59(9):2306-2314.
52. O'Loughlin A., McIntosh C., Dinneen S.F., O'Brien T. Review paper: basic concepts to novel therapies: a review of the diabetic foot. Int J Low Extrem Wounds 2010, 9(2):90-102.
53. Wetzler C., Kampfer H., Stallmeyer B., Pfeilschifter J., Frank S. Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol 2000, 115(2):245-253.
54. Nwomeh B.C., Liang H.X., Cohen I.K., Yager D.R. MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers. J Surg Res 1999, 81(2):189-195.
55. Yoshizaki A., Iwata Y., Komura K., Ogawa F., Hara T., Muroi E., Takenaka M., Shimizu K., Hasegawa M., Fujimoto M., et al. CD19 regulates skin and lung fibrosis via toll-like receptor signaling in a model of bleomycin-induced scleroderma. Am J Pathol 2008, 172(6):1650-1663.
56. Stifano G., Affandi A.J., Mathes A.L., Rice L.M., Nakerakanti S., Nazari B., Lee J., Christmann R.B., Lafyatis R. Chronic toll-like receptor 4 stimulation in skin induces inflammation, macrophage activation, transforming growth factor beta signature gene expression, and fibrosis. Arthritis Res Ther 2014, 16(4):R136.
57. Bhattacharyya S., Kelley K., Melichian D.S., Tamaki Z., Fang F., Su Y., Feng G., Pope R.M., Budinger G.R., Mutlu G.M., et al. Toll-like receptor 4 signaling augments transforming growth factor-beta responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma. Am J Pathol 2013, 182(1):192-205.
58. Nikitorowicz-Buniak J., Shiwen X., Denton C.P., Abraham D., Stratton R. Abnormally differentiating keratinocytes in the epidermis of systemic sclerosis patients show enhanced secretion of CCN2 and S100A9. J Invest Dermatol 2014, 134(11):2693-2702.